Register for the 2nd TRP Target Selection & Drug Design Summit
Please select the appropriate price when booking. Bookings are subject to approval.
All prices are shown in USD.
Register by Friday, December, 12 & Save up to $800
Drug Developer Pricing*
Conference + Workshop Day
(Save $800)
$3,597
On the Door: $4,397
Conference Only
(Save $400)
$2,699
On the Door: $3,099
Academic Pricing**
Conference + Workshop Day
(Save $800)
$2,997
On the Door: $2,699
Conference Only
(Save $400)
$2,299
On the Door: $2,699
Service Provider Pricing***
Conference + Workshop Day
(Save $800)
$4,497
On the Door: $5,297
Conference Only
(Save $400)
$3,399
On the Door: $3,799
* To be eligible for this price, the group or individuals must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services.
** To be eligible for this price, the group or individual must be full-time academic(s).
*** If you are a solution or service provider, have you considered sponsoring this event? Sponsorship includes multiple passes at a discounted rate. Inquire to learn more.
Unlock Group Discounts
Maximize value for money using special team discounts: Please note that discounts are only valid when three or more delegates from one company book and pay at the same time.
10% Off
When registering 2 attendees from one company
15% Off
When registering 3 attendees from one company
20% Off
When registering 4+ attendees from one company
Need Assistance?
If you have any questions about registration pricing, discounts or would like help in the booking process, contact us and one of the team will get back to you.
Explore the Full Event Guide
- 100+ attendees from world-leading RLT companies
- 20+ expert speakers including Novartis, Bayer, AstraZeneca & Convergent Therapeutics
- 12+ C-Suite speakers with direct influence on their companies' pipelines
- 6+ novel targets explored, including PD-L1, DLL3, B7-H3, CEACAM5, KLK3 and COF-01
- 6+ Hours of Built-In Networking alongside pioneers in the RLT industry
- 3 Big Pharma Companies Presenting on the advancements in their RLT pipeline
